IN2014DN08260A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN08260A IN2014DN08260A IN8260DEN2014A IN2014DN08260A IN 2014DN08260 A IN2014DN08260 A IN 2014DN08260A IN 8260DEN2014 A IN8260DEN2014 A IN 8260DEN2014A IN 2014DN08260 A IN2014DN08260 A IN 2014DN08260A
- Authority
- IN
- India
- Prior art keywords
- telaprevir
- solvate
- preparation
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 5
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- BBAWEDCPNXPBQM-GDEBMMAJSA-N telaprevir Chemical compound N([C@H](C(=O)N[C@H](C(=O)N1C[C@@H]2CCC[C@@H]2[C@H]1C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1)C(C)(C)C)C1CCCCC1)C(=O)C1=CN=CC=N1 BBAWEDCPNXPBQM-GDEBMMAJSA-N 0.000 abstract 2
- 229960002935 telaprevir Drugs 0.000 abstract 2
- 108010017101 telaprevir Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000013067 intermediate product Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12159923 | 2012-03-16 | ||
| PCT/EP2013/055397 WO2013135870A1 (en) | 2012-03-16 | 2013-03-15 | Process for the synthesis of telaprevir, or pharmaceutically acceptable salts or solvates as well as intermediate products thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN08260A true IN2014DN08260A (https=) | 2015-05-15 |
Family
ID=47884350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN8260DEN2014 IN2014DN08260A (https=) | 2012-03-16 | 2013-03-15 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20150038677A1 (https=) |
| EP (1) | EP2825534A1 (https=) |
| IN (1) | IN2014DN08260A (https=) |
| WO (1) | WO2013135870A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004501191A (ja) * | 2000-06-28 | 2004-01-15 | テバ ファーマシューティカル インダストリーズ リミティド | カルベジロール |
| WO2007022459A2 (en) | 2005-08-19 | 2007-02-22 | Vertex Pharmaceuticals Incorporated | Processes and intermediates |
| US8399615B2 (en) | 2005-08-19 | 2013-03-19 | Vertex Pharmaceuticals Incorporated | Processes and intermediates |
-
2013
- 2013-03-15 IN IN8260DEN2014 patent/IN2014DN08260A/en unknown
- 2013-03-15 US US14/384,268 patent/US20150038677A1/en not_active Abandoned
- 2013-03-15 WO PCT/EP2013/055397 patent/WO2013135870A1/en not_active Ceased
- 2013-03-15 EP EP13709448.8A patent/EP2825534A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2825534A1 (en) | 2015-01-21 |
| US20150038677A1 (en) | 2015-02-05 |
| WO2013135870A1 (en) | 2013-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MD20150091A2 (ro) | Compuşi antivirali | |
| PH12014502605A1 (en) | Uracyl spirooxetane nucleosides | |
| PL2791093T3 (pl) | Sposób wytwarzania 2,3,3,3-tetrafluoropropenu | |
| IN2015DN00598A (https=) | ||
| MX361653B (es) | Procedimiento para la preparación de derivados del ácido biliar. | |
| PH12016501462A1 (en) | Neprilysin inhibitors | |
| WO2014125506A3 (en) | A process for the preparation of ivacaftor and its intermediates | |
| MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
| WO2012137227A3 (en) | Solid forms of antiretroviral compounds and anti-oxidative acids, processes for preparation and pharmaceutical compositions thereof | |
| HUP1300647A2 (hu) | Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik | |
| WO2013168176A3 (en) | Process for preparation of fosaprepitant and salt thereof | |
| PH12018500872A1 (en) | Innovative preparation and crystallization of iosimenol | |
| IN2015DN00950A (https=) | ||
| IN2014DN09451A (https=) | ||
| EP3337790A4 (en) | PROCESS FOR THE PREPARATION OF HYDROXYMETHYL FURFURAL DERIVATIVES | |
| HUE042626T2 (hu) | Eljárások a medetomidin szintézisnél hasznosítható vegyületek, például 3 aril-butiral-dehidek elõállítására | |
| ZA201803105B (en) | Industrial process for the preparation of (5s,10s)-10-benzyl-16-methyl-11,14,18-trioxo-15,17,19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium (e)-3-carboxyacrylate salt | |
| ZA201307451B (en) | Acadesine derivatives, products and compositions including same,therapeutic uses thereof and methods for synthesizing same | |
| WO2014159501A3 (en) | Processes for preparing tetrahydroisoquinolines | |
| WO2014030173A3 (en) | Improved process for preparation of atazanavir bisulfate | |
| WO2014102759A3 (en) | Process for the preparation of dasatinib and its intermediates | |
| SG11201403384WA (en) | Process for the preparation of an olefin product | |
| PL2581193T3 (pl) | Sposób wytwarzania implantów lub produktów pośrednich takich implantów, jak również implanty i produkty pośrednie otrzymane tym sposobem | |
| IN2014DN08260A (https=) | ||
| WO2017046816A3 (en) | Process for the preparation of derivatives of benzodioxole |